StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

NeoGenomics's total debt was $374.69M at Sep 30, 2026. For fiscal 2025 it was $341.86M, down 36.8% from the year before. Over ten years it grew 18.5% a year on average. The highest annual figure on record is $541.11M in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$341.86M-36.8%
FY2024Dec 31, 2024$541.11M+0.5%
FY2023Dec 31, 2023$538.20M+0.5%
FY2022Dec 31, 2022$535.39M+0.3%
FY2021Dec 31, 2021$533.69M+215.6%
FY2020Dec 31, 2020$169.09M+69.0%
FY2019Dec 31, 2019$100.03M-10.9%
FY2018Dec 31, 2018$112.30M+6.5%
FY2017Dec 31, 2017$105.42M-0.7%
FY2016Dec 31, 2016$106.17M+69.8%
FY2015Dec 31, 2015$62.51M+1797.7%
FY2013Dec 31, 2013$3.29M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$374.69M-30.4%
Q2 FY2026Jun 30, 2026$374.24M-30.1%
Q4 FY2025Dec 31, 2025$341.86M-35.9%
Q4 FY2024Dec 31, 2024$541.11M+1.4%
Q4 FY2023Dec 31, 2023$538.20M+0.9%
Q4 FY2022Dec 31, 2022$535.39M+0.4%
Q4 FY2021Dec 31, 2021$533.69M+215.6%
Q3 FY2021Sep 30, 2021$533.50M+217.9%
Q2 FY2021Jun 30, 2021$533.44M+220.5%
Q1 FY2021Mar 31, 2021$533.15M+417.8%
Q4 FY2020Dec 31, 2020$169.09M+69.0%
Q3 FY2020Sep 30, 2020$167.84M+54.0%
Q2 FY2020Jun 30, 2020$166.45M+51.5%
Q1 FY2020Mar 31, 2020$102.97M-6.9%
Q4 FY2019Dec 31, 2019$100.03M-10.9%
Q3 FY2019Sep 30, 2019$109.01M-1.2%
Q2 FY2019Jun 30, 2019$109.86M-20.7%
Q1 FY2019Mar 31, 2019$110.62M+9.5%
Q4 FY2018Dec 31, 2018$112.30M+6.5%
Q3 FY2018Sep 30, 2018$110.32M+5.0%
Q2 FY2018Jun 30, 2018$138.53M+26.7%
Q1 FY2018Mar 31, 2018$101.04M+1.2%
Q4 FY2017Dec 31, 2017$105.42M-0.7%
Q3 FY2017Sep 30, 2017$105.06M–
Q2 FY2017Jun 30, 2017$109.31M–
Q1 FY2017Mar 31, 2017$99.88M–
Q4 FY2016Dec 31, 2016$106.17M–

More NeoGenomics figures

See a number that looks wrong?